226 related articles for article (PubMed ID: 29712422)
41. Characterization of the role of para-aminobenzoic acid biosynthesis in folate production by Lactococcus lactis.
Wegkamp A; van Oorschot W; de Vos WM; Smid EJ
Appl Environ Microbiol; 2007 Apr; 73(8):2673-81. PubMed ID: 17308179
[TBL] [Abstract][Full Text] [Related]
42. Single photon emission computed tomography and positron emission tomography in cancer imaging.
Coleman RE
Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
[TBL] [Abstract][Full Text] [Related]
43. From Carbon-11-Labeled Amino Acids to Peptides in Positron Emission Tomography: the Synthesis and Clinical Application.
Pekošak A; Filp U; Poot AJ; Windhorst AD
Mol Imaging Biol; 2018 Aug; 20(4):510-532. PubMed ID: 29411226
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system.
Wilson AA; Sadovski O; Nobrega JN; Raymond RJ; Bambico FR; Nashed MG; Garcia A; Bloomfield PM; Houle S; Mizrahi R; Tong J
Nucl Med Biol; 2017 Oct; 53():14-20. PubMed ID: 28719807
[TBL] [Abstract][Full Text] [Related]
45. Neuronuclear assessment of patients with epilepsy.
Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
[TBL] [Abstract][Full Text] [Related]
46. Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.
Maisonial A; Kuhnast B; Papon J; Boisgard R; Bayle M; Vidal A; Auzeloux P; Rbah L; Bonnet-Duquennoy M; Miot-Noirault E; Galmier MJ; Borel M; Askienazy S; Dollé F; Tavitian B; Madelmont JC; Moins N; Chezal JM
J Med Chem; 2011 Apr; 54(8):2745-66. PubMed ID: 21417462
[TBL] [Abstract][Full Text] [Related]
47. Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens.
Bocan TM; Panchal RG; Bavari S
Mol Imaging Biol; 2015 Feb; 17(1):4-17. PubMed ID: 25008802
[TBL] [Abstract][Full Text] [Related]
48. Determination of metabolic stability of positron emission tomography tracers by LC-MS/MS: an example in WAY-100635 and two analogues.
Lavén M; Itsenko O; Markides K; Långström B
J Pharm Biomed Anal; 2006 Mar; 40(4):943-51. PubMed ID: 16388927
[TBL] [Abstract][Full Text] [Related]
49. Imaging of Actively Proliferating Bacterial Infections by Targeting the Bacterial Metabolic Footprint with d-[5-
Renick PJ; Mulgaonkar A; Co CM; Wu CY; Zhou N; Velazquez A; Pennington J; Sherwood A; Dong H; Castellino L; Öz OK; Tang L; Sun X
ACS Infect Dis; 2021 Feb; 7(2):347-361. PubMed ID: 33476123
[TBL] [Abstract][Full Text] [Related]
50. Screening cascade and development of potential Positron Emission Tomography radiotracers for mGluR5: in vitro and in vivo characterization.
Patel S; Ndubizu O; Hamill T; Chaudhary A; Burns HD; Hargreaves R; Gibson RE
Mol Imaging Biol; 2005; 7(4):314-23. PubMed ID: 16080024
[TBL] [Abstract][Full Text] [Related]
51. Susceptibility of
Naqvi SAR; Roohi S; Sabir H; Shahzad SA; Aziz A; Rasheed R
Appl Biochem Biotechnol; 2019 Jun; 188(2):424-435. PubMed ID: 30515632
[No Abstract] [Full Text] [Related]
52. Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT.
Rempel BP; Price EW; Phenix CP
Mol Imaging; 2017; 16():1536012117717852. PubMed ID: 28927325
[TBL] [Abstract][Full Text] [Related]
53. Radiotracers for imaging of Parkinson's disease.
Abbasi Gharibkandi N; Hosseinimehr SJ
Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
[TBL] [Abstract][Full Text] [Related]
54. Towards clinical application of non-invasive imaging to detect bacterial infections.
Ohlsen K; Hertlein T
Virulence; 2018 Dec; 9(1):943-945. PubMed ID: 29417876
[TBL] [Abstract][Full Text] [Related]
55. Development of carbon-11 labelled PET tracers-radiochemical and technological challenges in a historic perspective.
Antoni G
J Labelled Comp Radiopharm; 2015 Mar; 58(3):65-72. PubMed ID: 25684179
[TBL] [Abstract][Full Text] [Related]
56. Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging.
Bockisch A; Freudenberg LS; Schmidt D; Kuwert T
Semin Nucl Med; 2009 Jul; 39(4):276-89. PubMed ID: 19497404
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
58. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
59. Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model.
Ocak M; Gillman AG; Bresee J; Zhang L; Vlad AM; Müller C; Schibli R; Edwards WB; Anderson CJ; Gach HM
Mol Pharm; 2015 Feb; 12(2):542-53. PubMed ID: 25536192
[TBL] [Abstract][Full Text] [Related]
60. [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.
Wilson AA; Garcia A; Parkes J; Houle S; Tong J; Vasdev N
Nucl Med Biol; 2011 Feb; 38(2):247-53. PubMed ID: 21315280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
